Duopharma to invest over RM1m to boost digital health growth

Group managing director Leonard Ariff Abdul Shatar Duopharma Biotech group managing director Leonard Ariff Abdul Shatar said one of the group’s primary strategies is the innovative use of emerging technologies to provide smarter solutions for a healthier life for all.

KUALA LUMPUR: Leading Malaysian pharmaceutical company, Duopharma Biotech Bhd has agreed to invest US$250,000 (RM1.09mil) in Naluri Hidup Sdn Bhd (Naluri) to spur Malaysia’s digital health growth.

Duopharma Biotech said Naluri, a local pioneer in digital therapeutics, has developed a proprietary application platform called "Naluri App”.